Skip to main content

. 1988 Feb;32(2):287. doi: 10.1128/aac.32.2.287

Pyrazinamide is not effective against intracellularly growing Mycobacterium tuberculosis.

N Rastogi, M C Potar, H L David

PMCID: PMC172157 PMID: 3129990

287

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Acocella G., Carlone N. A., Cuffini A. M., Cavallo G. The penetration of rifampicin, pyrazinamide, and pyrazinoic acid into mouse macrophages. Am Rev Respir Dis. 1985 Dec;132(6):1268–1273. doi: 10.1164/arrd.1985.132.6.1268. [DOI] [PubMed] [Google Scholar]
Carlone N. A., Acocella G., Cuffini A. M., Forno-Pizzoglio M. Killing of macrophage-ingested mycobacteria by rifampicin, pyrazinamide, and pyrazinoic acid alone and in combination. Am Rev Respir Dis. 1985 Dec;132(6):1274–1277. doi: 10.1164/arrd.1985.132.6.1274. [DOI] [PubMed] [Google Scholar]
Crowle A. J., Sbarbaro J. A., May M. H. Inhibition by pyrazinamide of tubercle bacilli within cultured human macrophages. Am Rev Respir Dis. 1986 Nov;134(5):1052–1055. doi: 10.1164/arrd.1986.134.5.1052. [DOI] [PubMed] [Google Scholar]
David H. L., Rastogi N., Clavel-Sérès S., Clément F., Thorel M. F. Structure of the cell envelope of Mycobacterium avium. Zentralbl Bakteriol Mikrobiol Hyg A. 1987 Apr;264(1-2):49–66. doi: 10.1016/s0176-6724(87)80124-4. [DOI] [PubMed] [Google Scholar]
MACKANESS G. B. The intracellular activation of pyrazinamide and nicotinamide. Am Rev Tuberc. 1956 Nov;74(5):718–728. doi: 10.1164/artpd.1956.74.5.718. [DOI] [PubMed] [Google Scholar]
Stottmeier K. D., Beam R. E., Kubica G. P. Determination of drug susceptibility of mycobacteria to pyrazinamide in 7H10 agar. Am Rev Respir Dis. 1967 Nov;96(5):1072–1075. doi: 10.1164/arrd.1967.96.5.1072. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES